Back to Journals » Therapeutics and Clinical Risk Management » Volume 15

Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapy

Total article views   HTML views PDF downloads Totals
11,344 Dovepress* 7,812+ 1,652 9,464
PubMed Central* 3,532 493 4,025
Totals 11,344 2,145 13,489
*Since 11 April 2019

View citations on PubMed Central and Google Scholar